ArticleThe Lancet. Oncology2019

Study evidence confirms current clinical practice in refractory metastatic colorectal cancer: the ReDOS trial.

Ralf-Dieter Hofheinz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.